US Patent Issued to AKRIBES BIOMEDICAL on Dec. 16 for "Selective glucocorticoid receptor modifiers for treating impaired skin wound healing" (Austrian Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,304, issued on Dec. 16, was assigned to AKRIBES BIOMEDICAL GMBH (Vienna).

"Selective glucocorticoid receptor modifiers for treating impaired skin wound healing" was invented by Barbara Wolff-Winiski (Vienna), Anton Stutz (Vienna), Nicole Schofmann (Vienna) and Petra Dorfler (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a Selective Glucocorticoid Receptor Modulator (SEGRM), or a pharmaceutically acceptable salt thereof, for use in the treatment of impaired skin wound healing in a subject, an in vitro method for identifying a subject suffering from impaired skin wound healing to be responsive to the treatment ...